Cellular Therapy & Immunobiology Working Party (CTIWP)
Study type:
Study number:
8420013
Type of treatment:
Diseases:
Acute Myeloid Leukaemia (AML)
Myelodysplastic (MDS) or MDS/MPN
Short title:
KIR
Primary objective:
Key inclusion criteria:
Country:
Principal investigator:
Johannes Schetelig
Study coordinator email:
ctiwpebmt@lumc.nl